Nav: Home

Study shows possible 'key' to improved therapy for adrenocortical carcinoma

May 09, 2016

A study comprised of 39 international institutions revealed significant new findings about adrenocortical carcinoma (ACC), a rare cancer with an often poor prognosis.

The study, which conducted a comprehensive "pan-genomic" assessment of ACC, was led by The University of Texas MD Anderson Cancer Center and the University of Michigan, Ann Arbor. Research results are published in the May 9 issue of Cancer Cell.

ACC is an aggressive cancer originating in the adrenal gland. The disease affects less than two people per million annually, and is seen more commonly in children under age 5 and adults ages 30-40. The overall five-year survival rate is 20 to 35 percent.

Scientists examined 91 ACC tumor specimens from four continents, and observed "massive" DNA loss followed by whole genome doubling (WGD). WGD occurs when tumor cells acquire an extra copy of their entire genome. The researchers found that WGD was associated with aggressive clinical course, suggesting that it could be a hallmark of disease progression. They speculate that tumor growth could be slowed if they could prohibit WGD in future pre-clinical studies.

"Our results represent the most complete characterization of ACC tissues and may indicate a key to successful targeted therapy for this disease," said Roeland Verhaak, Ph.D., associate professor of Bioinformatics and Computational Biology. "The study findings illustrate how molecular data, combined with traditional clinical assessment, might inform therapeutic decisions and lead to significant advances in patient outcomes."

In addition, the study identified three ACC subtypes with distinct clinical outcomes and molecular alterations, said Verhaak, paving the way for a more precise clinical stratification of patients based on molecular biomarkers.

The team also identified novel ACC "driver" genes, expanding their understanding about genes already thought to lead to tumor formation, as well as defining new molecular pathways.

"Our understanding of ACC pathogenesis is incomplete and new therapies are needed," said Verhaak. "While standard clinical assessments are informative for patient management, molecular information may be able to more precisely predict patient outcome and direct optimal care."

The study relied on cancer molecular data provided through The Cancer Genome Atlas (TCGA).
-end-
MD Anderson members of the study team included Siyuan Zheng, Ph.D., Genomic Medicine, Rehan Akbani, Ph.D., Bioinformatics and Computational Biology, and Mouhammed Habra, M.D., Endocrine Neoplasia and Hormonal Disorders.

U.S. institutions participating in the study included the Massachusetts Institute of Technology and Harvard University, and Harvard Medical School, Cambridge, Mass.; Baylor College of Medicine, Houston; University of North Carolina at Chapel Hill, N.C.; Johns Hopkins University; University of Michigan, Ann Arbor; Memorial Sloan-Kettering Cancer Center, New York; University of California, Santa Cruz; Dana-Farber Cancer Institute, Boston; Brown University, Providence, R.I.; Brigham and Women's Hospital, Boston; Translational Genomics Research Institute, Phoenix; Institute for Systems Biology, Seattle; the National Institutes of Health and National Cancer Institute, Bethesda, Md.; and Arizona State University, Tempe, Ariz. In addition, 16 international institutions also participated in the study.

The study was funded by the National Institutes of Health (5U24CA143799, 5U24CA143835, 5U24CA143840, 5U24CA143843, 5U24CA143845, 5U24CA143848, 5U24CA143858, 5U24CA143866, 5U24CA143867, 5U24CA143882, 5U24CA143883, 5U24CA144025, U54HG003067, U54HG003079, U54HG003273 and P30CA16672).

University of Texas M. D. Anderson Cancer Center

Related Genes Articles:

How status sticks to genes
Life at the bottom of the social ladder may have long-term health effects that even upward mobility can't undo, according to new research in monkeys.
Symphony of genes
One of the most exciting discoveries in genome research was that the last common ancestor of all multicellular animals already possessed an extremely complex genome.
New genes out of nothing
One key question in evolutionary biology is how novel genes arise and develop.
Good genes
A team of scientists from NAU, Arizona State University, the University of Groningen in the Netherlands, the Center for Coastal Studies in Massachusetts and nine other institutions worldwide to study potential cancer suppression mechanisms in cetaceans, the mammalian group that includes whales, dolphins and porpoises.
How lifestyle affects our genes
In the past decade, knowledge of how lifestyle affects our genes, a research field called epigenetics, has grown exponentially.
Genes that regulate how much we dream
Sleep is known to allow animals to re-energize themselves and consolidate memories.
The genes are not to blame
Individualized dietary recommendations based on genetic information are currently a popular trend.
Timing is everything, to our genes
Salk scientists discover critical gene activity follows a biological clock, affecting diseases of the brain and body.
New genes on 'deteriorating' Y chromosome
Decoding Y chromosomes is difficult even with latest sequencing technologies.
Newly revealed autism-related genes include genes involved in cancer
Researchers in Italy have applied a computational technique that accounts for how genes interact, to find new networks of related genes that may be involved in autism spectrum disorder.
More Genes News and Genes Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Climate Mindset
In the past few months, human beings have come together to fight a global threat. This hour, TED speakers explore how our response can be the catalyst to fight another global crisis: climate change. Guests include political strategist Tom Rivett-Carnac, diplomat Christiana Figueres, climate justice activist Xiye Bastida, and writer, illustrator, and artist Oliver Jeffers.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at Radiolab.org/donate.